Month: September 2020

CALABASAS, Calif., Sept. 25, 2020 (GLOBE NEWSWIRE) — NETSOL Technologies, Inc. (Nasdaq: NTWK), a global business services and enterprise application solutions provider, today announced that it has rescheduled its fiscal fourth quarter and full year 2020 conference call, which was previously scheduled for Thursday, September 24, 2020, to Monday, September 28 at 9:00 a.m. Eastern time (6:00 a.m. Pacific time). During the call, the Company will discuss its results for the fiscal fourth quarter and full year ended June 30, 2020. Financial results will be issued in a press release prior to the call.NETSOL management will host the presentation, followed by a question and answer period.Date: Monday, September 28, 2020Time: 9:00 a.m. Eastern time (6:00 a.m. Pacific time)U.S. dial-in: 1-877-407-0789International dial-in: 1-201-689-8562Please...

GLYFADA, Greece, Sept. 25, 2020 (GLOBE NEWSWIRE) — Globus Maritime Limited (“Globus,” the “Company,” “we,” or “our”) (NASDAQ: GLBS), a dry bulk shipping company, today reported its unaudited consolidated operating and financial results for the six-month period ended June 30, 2020.Financial HighlightsCurrent Fleet ProfileAs of the date of this press release, Globus’ subsidiaries own and operate five dry bulk carriers, consisting of four Supramax and one Panamax.Current Fleet DeploymentAll our vessels are currently operating on short-term time charters (“on spot”).Management CommentaryIt was at this time that we successfully tapped the capital markets and completed offerings and private placements, raising significant capital.  We also initiated discussions for debt financing to support potential vessel acquisitions, when and if we...

SAN ANTONIO, Sept. 25, 2020 (GLOBE NEWSWIRE) — Usio, Inc. (Nasdaq: USIO), an integrated electronic payment solutions provider, today announced the closing of an underwritten public offering of common stock for gross proceeds of approximately $8 million, prior to deducting underwriting discounts and commissions and offering expenses payable by Usio.The offering was comprised of shares of common stock priced at a public offering price of $1.70 per share.Ladenburg Thalmann & Co. Inc. is acting as sole book-running manager in connection with the offering. Barrington Research Associates, Inc. is acting as co-manager in the offering.A total of 4,705,883 shares of common stock were issued in the offering. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 705,882 shares of common...

MIDLAND, Texas, Sept. 25, 2020 (GLOBE NEWSWIRE) — Rattler Midstream LP (NASDAQ: RTLR) (“Rattler”), a subsidiary of Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback”), today announced that it plans to release third quarter 2020 financial results on November 4, 2020 after the market closes.In connection with the earnings release, Rattler will host a conference call and webcast for investors and analysts to discuss its results for the third quarter of 2020 on Thursday, November 5, 2020 at 9:00 a.m. CT. Participants should call (877) 288-2756 (United States/Canada) or (470) 495-9481 (International) and use the confirmation code 4374698. A telephonic replay will be available from 12:00 p.m. CT on Thursday, November 5, 2020 through Thursday, November 12, 2020 at 12:00 p.m. CT. To access the replay, call (855) 859-2056 (United States/Canada)...

MIDLAND, Tx., Sept. 25, 2020 (GLOBE NEWSWIRE) — Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback”), today announced that it plans to release third quarter 2020 financial results on November 2, 2020 after the market closes.In connection with the earnings release, Diamondback will host a conference call and webcast for investors and analysts to discuss its results for the third quarter of 2020 on Tuesday, November 3, 2020 at 8:00 a.m. CT. Participants should call (877) 440-7573 (United States/Canada) or (253) 237-1144 (International) and use the confirmation code 2493666. A telephonic replay will be available from 11:00 a.m. CT on Tuesday, November 3, 2020, through Tuesday, November 10, 2020 at 11:00 a.m. CT. To access the replay, call (855) 859-2056 (United States/Canada) or (404) 537-3406 (International) and enter confirmation...

MIDLAND, Texas, Sept. 25, 2020 (GLOBE NEWSWIRE) — Viper Energy Partners LP (NASDAQ: VNOM) (“Viper”), a subsidiary of Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback”), today announced that it plans to release third quarter 2020 financial results on November 2, 2020 after the market closes.In connection with the earnings release, Viper will host a conference call and webcast for investors and analysts to discuss its results for the third quarter of 2020 on Tuesday, November 3, 2020 at 10:00 a.m. CT. Participants should call (844) 400-1537 (United States/Canada) or (703) 326-5198 (International) and use the confirmation code 3361815. A telephonic replay will be available from 1:00 p.m. CT on Tuesday, November 3, 2020, through Tuesday, November 10, 2020 at 1:00 p.m. CT. To access the replay, call (855) 859-2056 (United States/Canada)...

– Brown Advisory, Greenhouse Funds and TT Investimentos to Participate in an Offering of Common Stock Expected to Provide Greater Optionality in Evaluating Market Opportunities and Facilitate Future Growth ‐SALT LAKE CITY, Sept. 25, 2020 (GLOBE NEWSWIRE) — Clarus Corporation (NASDAQ: CLAR) (“Clarus” and/or the “Company”), a company focused on the outdoor and consumer industries, announced today that it has entered into an agreement with three of its top 10 investors (the “Investors”) for the sale of 900,000 registered shares of the Company’s common stock at $12.75 for total proceeds of approximately $11.5 million.The Investors—Brown Advisory, Greenhouse Funds and TT Investimentos— have each determined to increase their investment in recognition of management’s past execution and in support of the Company’s long‐term growth...

Lima, Sept. 25, 2020 (GLOBE NEWSWIRE) — Lima, PERU, September 25, 2020 — Credicorp (NYSE: BAP) invites institutional investors and sell-side analysts to participate in its virtual Investor Day, commemorating Credicorp’s 25th Anniversary of its listing in the New York Stock Exchange. Presentations and a Q&A session will take place on October 1, 2020.Time:8:30 – 11:00 PET9:30 – 12:00 ET14:30 – 17:00 BTPresenters include:Mr. Luis Enrique Romero, Executive ChairmanMr. Walter Bayly, CEOMr. Gianfranco Ferrari, Deputy CEO and CEO of BCPMr. Javier Ichazo, Head of Microfinance and CEO of MibancoMr. Alvaro Correa, Deputy CEO, Head of Insurance & Pensions, IB &WMMr. Eduardo Montero, Head of IB & WMMr. Cesar Rios, CFOTo register for the event, please visit credicorpday.comPresentation materials and a webcast replay...

RESULTATS SEMESTRIELS 2020Paris, le 25 septembre 2020Patrimoine161,3 Millions d’euros (avant cession de l’immeuble Bizet post-clôture)Résultat net consolidé(Part du groupe)–  1 817 K€Actif net réévalué(Part du groupe)141 698 K€ANR par action au 30/06/20200,96 € / actionUn patrimoine immobilier de grande qualité évalué à 161,3 millions d’euros constitué d’immeubles de placements, uniquement en baisse de 1,2% par rapport au 31 décembre 2019 dans un contexte sanitaire difficile.Plus de 95% du patrimoine en valeur est localisé à Paris dans le QCA (Quartier Central des Affaires).Le patrimoine en valeur est essentiellement composé de surfaces de bureaux et de commerces, permettant d’offrir une rentabilité régulière dans une zone où la demande est importante.Cours du 25/09/20200,409 € / actionChiffres clés de l’activité(1)    Les intérêts...

– Fetal Hemoglobin expression in human cellular models increased up to ~30% by FTX-6058 for the potential treatment of sickle-cell disease– Company plans to initiate Phase 1 trial in healthy volunteers by year-end– Non-provisional composition of matter patent application covering FTX-6058 publishedCAMBRIDGE, Mass., Sept. 25, 2020 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced preclinical proof-of-concept data supporting the development of FTX-6058 to treat sickle cell disease and beta-thalassemia. FTX-6058, a small molecule designed to increase expression of fetal hemoglobin, demonstrated target engagement and good tolerability in multiple preclinical rodent...